Analysis of new biomarkers for cholangiocarcinoma

被引：5

作者：

Miwa, Masanao ^{[1
]}

You, Gyokukou ^{[1
]}

Tanaka, Hideaki ^{[1
]}

Taniguchi, Seigo ^{[1
]}

Fujii, Takahiro ^{[1
]}

Kamemura, Kazuo ^{[1
]}

Suzaki, Masafumi ^{[2
]}

Isono, Takahiro ^{[2
]}

Tooyama, Ikuo ^{[2
]}

Tanaka, Masakazu ^{[3
]}

Srivatanakul, Petcharin ^{[4
]}

Viwatthanasittiphong, Chutiwan ^{[5
]}

Sangrajrang, Suleeporn ^{[4
]}

Khuhaprema, Thiravud ^{[4
]}

机构：

[1] Nagahama Inst Biosci & Technol, Nagahama, Shiga 5260829, Japan

[2] Shiga Univ Med Sci, Otsu, Shiga 52021, Japan

[3] Kansai Med Univ, Hirakata, Osaka, Japan

[4] Natl Canc Inst, Bangkok, Thailand

[5] Ubon Canc Ctr, Ratchathani, Thailand

来源：

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES | 2014年 / 21卷 / 06期

关键词：

Biliary tract cancer; Cholangiocarcinoma; Opisthorchis viverrini; Tumor marker; WISTERIA-FLORIBUNDA AGGLUTININ; OPISTHORCHIS-VIVERRINI; THAILAND; CANCER; RISK; MARKER;

D O I：

10.1002/jhbp.69

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Cholangiocarcinoma is one of the most serious diseases in northeast Thailand, where its incidence is reported to be the highest in the world. We tried to develop a new method to detect cholangiocarcinoma in the early stages using serum proteins. We found that after fluorescent labeling of the sugar moiety of serum proteins, a new peak was identified, which might be a promising marker for cholangiocarcinoma.

引用

页码：397 / 398

页数：2

共 50 条

[31] Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma
Bernuzzi, F.
Marabita, F.
Lleo, A.
Carbone, M.
Mirolo, M.
Marzioni, M.
Alpini, G.
Alvaro, D.
Boberg, K. M.
Locati, M.
Torzilli, G.
Rimassa, L.
Piscaglia, F.
He, X. -S.
Bowlus, C. L.
Yang, G. -X.
Gershwin, M. E.
Invernizzi, P.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2016, 185 (01) : 61 - 71
[32] Diagnostic value of microRNAs as biomarkers for cholangiocarcinoma
Liang, Zhenzhen
Liu, Xin
Zhang, Qian
Wang, Chunpeng
Zhao, Yinlong
DIGESTIVE AND LIVER DISEASE, 2016, 48 (10) : 1227 - 1232
[33] Prognostic biomarkers for cholangiocarcinoma and their clinical implications
Saengboonmee, Charupong
Sawanyawisuth, Kanlayanee
Chamgramol, Yaovalux
Wongkham, Sopit
EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (06) : 579 - 592
[34] Molecular Biomarkers in Cholangiocarcinoma: Focus on Bile
Dolbnya, Andrey D.
Popov, Igor A.
Pekov, Stanislav I.
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2024, 24 (08) : 722 - 736
[35] Pesticides, Fresh Water Fish, Liver Flukes and Nitrosamines: A Story of Cholangiocarcinoma Development in Thailand
Wiwanitkit, Viroj
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2009, 10 (05)
[36] Quantitative proteomic analysis of bile in extrahepatic cholangiocarcinoma patients
Son, Kuk Hui
Ahn, Chi Bum
Kim, Hyo Jung
Kim, Jae Seon
JOURNAL OF CANCER, 2020, 11 (14): : 4073 - 4080
[37] The new insight of treatment in Cholangiocarcinoma
Li, Yuhang
Song, Yinghui
Liu, Sulai
JOURNAL OF CANCER, 2022, 13 (02): : 450 - 464
[38] Biomarkers for the Diagnosis of Cholangiocarcinoma: A Systematic Review
Tshering, Gyem
Dorji, Palden Wangyel
Chaijaroenkul, Wanna
Na-Bangchang, Kesara
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 98 (06) : 1788 - 1797
[39] Next-Generation Biomarkers for Cholangiocarcinoma
Rodrigues, Pedro M.
Vogel, Arndt
Arrese, Marco
Balderramo, Domingo C.
Valle, Juan W.
Banales, Jesus M.
CANCERS, 2021, 13 (13)
[40] Biomarkers for the Evaluation of Immunotherapy in Patients with Cholangiocarcinoma
Bousou, Thaleia-Eleftheria
Sarantis, Panagiotis
Anastasiou, Ioanna A.
Trifylli, Eleni-Myrto
Liapopoulos, Dimitris
Korakaki, Dimitra
Koustas, Evangelos
Katsimpoulas, Michalis
Karamouzis, Michalis V.
CANCERS, 2025, 17 (03)

← 1 2 3 4 5 →